BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance
Clinical trial NCT02029638 · TERMINATED
Trial details
- NCT number
- NCT02029638
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-07
- Primary completion
- 2017-09-06
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.